Upcoming RNA-Seq Webinar

Using IPA® to analyze Illumina RNA-Seq data reveals abundance-specific biological signatures in Alzheimer’s Disease

Date: Monday, October 10, 2011     Time: 9:00 a.m. (PST)
Speaker: Darryl Gietzen, Ph.D., Field Application Scientist, Ingenuity Systems

IPA was used to interpret Alzheimer’s disease biology by comparing Illumina RNA-Seq data from Alzheimer’s disease (AD) and normal brain samples. This analysis revealed very specific biological changes in certain classes of transcript expression, demonstrating how the unique benefits of RNA-Seq can help characterize disease changes.

In this webinar, we will discuss how:

  • IPA maximizes RNA-Seq data analysis
  • Grouping and analyzing all significantly changed genes in RNA-Seq data can provide pathway level information
  • The sensitivity and accuracy of RNA-Seq enables pathway analysis on a subset of genes to elucidate more subtle biological changes